{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:35Z","timestamp":1786982255473,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12105-018-0887-5","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T02:55:16Z","timestamp":1518144916000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma"],"prefix":"10.1007","volume":"12","author":[{"given":"Diana","family":"Bell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,9]]},"reference":[{"issue":"Suppl 1","key":"887_CR1","doi-asserted-by":"publisher","first-page":"E2259","DOI":"10.1002\/hed.24152","volume":"38","author":"D Bell","year":"2016","unstructured":"Bell D, Hanna EY, Weber RS, et al. Neuroendocrine neoplasms of the sinonasal region. Head Neck. 2016;38(Suppl 1):E2259\u201366.","journal-title":"Head Neck."},{"issue":"4","key":"887_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s12022-016-9432-9","volume":"27","author":"S Rosa La","year":"2016","unstructured":"La Rosa S, Sessa F, Uccella S. Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs): unifying the concept of a heterogeneous group of neoplasms. Endocr Pathol. 2016;27(4):284\u2013311.","journal-title":"Endocr Pathol."},{"issue":"1","key":"887_CR3","first-page":"14","volume":"109","author":"S Uccella","year":"2017","unstructured":"Uccella S, Ottini G, Facco C, et al. Neuroendocrine neoplasms of the head and neck and olfactory neuroblastoma. Diagnosis classification. Pathologica. 2017;109(1):14\u201330.","journal-title":"Pathologica"},{"issue":"3","key":"887_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jtho.2016.11.2222","volume":"12","author":"AE Hendifar","year":"2017","unstructured":"Hendifar AE, Marchevsky AM, Tuli R. Neuroendocrine tumors of the lung: current challenges and advances in the diagnosis and management of well-differentiated disease. J Thorac Oncol. 2017;12(3):425\u201336.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"887_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12105-012-0379-y","volume":"7","author":"S Rosa La","year":"2013","unstructured":"La Rosa S, Furlan D, Franzi F, et al. Mixed exocrine-neuroendocrine carcinoma of the nasal cavity: clinico-pathologic and molecular study of a case and review of the literature. Head Neck Pathol. 2013;7(1):76\u201384.","journal-title":"Head Neck Pathol"},{"issue":"Suppl 2","key":"887_CR6","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1055\/s-0034-1390014","volume":"18","author":"SY Su","year":"2014","unstructured":"Su SY, Bell D, Hanna EY. Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment. Int Arch Otorhinolaryngol. 2014;18(Suppl 2):S149\u201356.","journal-title":"Int Arch Otorhinolaryngol"},{"key":"887_CR7","first-page":"21","volume-title":"WHO classification of tumors of the head and neck. 4th ed. Tumors of the nasal cavity, paranasal sinuses and skull base","author":"LDR Thompson","year":"2017","unstructured":"Thompson LDR, Bell D, Bishop JA. Neuroendocrine carcinomas. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumors of the head and neck. 4th ed. Tumors of the nasal cavity, paranasal sinuses and skull base. Lyon: IAC Press; 2017. pp.\u00a021\u20133."},{"issue":"10","key":"887_CR8","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/hed.21940","volume":"34","author":"EH Mitchell","year":"2012","unstructured":"Mitchell EH, Diaz A, Yilmaz T, et al. Multimodality treatment for sinonasal neuroendocrine carcinoma. Head Neck. 2012;34(10):1372\u20136.","journal-title":"Head Neck"},{"issue":"3","key":"887_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/modpathol.3880522","volume":"15","author":"SE Mills","year":"2002","unstructured":"Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol. 2002;15(3):264\u201378.","journal-title":"Mod Pathol"},{"issue":"11","key":"887_CR10","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1002\/cncr.20693","volume":"101","author":"DI Rosenthal","year":"2004","unstructured":"Rosenthal DI, Barker JL Jr, El-Naggar AK, et al. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer. 2004;101(11):2567\u201373.","journal-title":"Cancer"},{"issue":"3","key":"887_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1586\/era.13.1","volume":"13","author":"D Bell","year":"2013","unstructured":"Bell D, Hanna EY. Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markers. Expert Rev Anticancer Ther. 2013;13(3):285\u201396.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"887_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/j.seminoncol.2006.10.024","volume":"34","author":"G Renner","year":"2007","unstructured":"Renner G. Small cell carcinoma of the head and neck: a review. Semin Oncol. 2007;34(1):3\u201314.","journal-title":"Semin Oncol"},{"issue":"4","key":"887_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1017\/S0022215106000594","volume":"120","author":"E Babin","year":"2006","unstructured":"Babin E, Rouleau V, Vedrine PO, et al. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. J Laryngol Otol. 2006;120(4):289\u201397.","journal-title":"J Laryngol Otol"},{"issue":"10","key":"887_CR14","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1002\/cncr.10537","volume":"94","author":"MM Fitzek","year":"2002","unstructured":"Fitzek MM, Thornton AF, Varvares M, et al. Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer. 2002;94(10):2623\u201334.","journal-title":"Cancer"},{"key":"887_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oraloncology.2016.10.002","volume":"63","author":"TP Laan van der","year":"2016","unstructured":"van der Laan TP, Iepsma R, Witjes MJ, van der Laan BF, Plaat BE, Halmos GB. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: the importance of differentiation grade in determining treatment strategy. Oral Oncol. 2016;63:1\u20139.","journal-title":"Oral Oncol"},{"key":"887_CR16","unstructured":"Berger L, Luc R, Richard D. \u201cL\u2019esthesioneuroepitheliome Olfactif.\u201d Bulletin de l\u2019Association Fran?aise pour l\u2019\u00e9tude du Cancer.vol 13. 1924. pp.\u00a0410\u201321."},{"key":"887_CR17","first-page":"57","volume-title":"WHO classification of tumors of the head and neck. 4th ed. Tumors of the nasal cavity, paranasal sinuses and skull base","author":"D Bell","year":"2017","unstructured":"Bell D, Franchi A, Gillison M, Thompson LDR, Wenig BM. Olfactory neuroblastoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumors of the head and neck. 4th ed. Tumors of the nasal cavity, paranasal sinuses and skull base. Lyon: IAC Press; 2017. pp.\u00a057\u20139."},{"key":"887_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.anndiagpath.2016.04.001","volume":"22","author":"M Holmes","year":"2016","unstructured":"Holmes M, Su SY, Bell D. Ectopic primary olfactory neuroblastoma of the maxillary sinus. Ann Diagn Pathol. 2016;22:45\u20138.","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"887_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nec.2012.08.005","volume":"24","author":"TJ Ow","year":"2013","unstructured":"Ow TJ, Bell D, Kupferman ME, Demonte F, Hanna EY. Esthesioneuroblastoma. Neurosurg Clin N Am. 2013;24(1):51\u201365.","journal-title":"Neurosurg Clin N Am"},{"issue":"5","key":"887_CR20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/PAP.0b013e3181b544cf","volume":"16","author":"H Faragalla","year":"2009","unstructured":"Faragalla H, Weinreb I. Olfactory neuroblastoma: a review and update. Adv Anat Pathol. 2009;16(5):322\u201331.","journal-title":"Adv Anat Pathol"},{"issue":"8","key":"887_CR21","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/lary.21856","volume":"121","author":"EH Holbrook","year":"2011","unstructured":"Holbrook EH, Wu E, Curry WT, Lin DT, Schwob JE. Immunohistochemical characterization of human olfactory tissue. Laryngoscope. 2011;121(8):1687\u2013701.","journal-title":"Laryngoscope"},{"issue":"2","key":"887_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.molmed.2016.12.010","volume":"23","author":"J Lavoie","year":"2017","unstructured":"Lavoie J, Gasso Astorga P, Segal-Gavish H, et al. The olfactory neural epithelium as a tool in neuroscience. Trends Mol Med. 2017;23(2):100\u20133.","journal-title":"Trends Mol Med"},{"issue":"1","key":"887_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12105-014-0547-3","volume":"9","author":"D Bell","year":"2015","unstructured":"Bell D, Saade R, Roberts D, et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015;9(1):51\u20139.","journal-title":"Head Neck Pathol"},{"issue":"3","key":"887_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/archotol.133.3.276","volume":"133","author":"D Jethanamest","year":"2007","unstructured":"Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma - A population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007;133(3):276\u201380.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"887_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1748-717X-6-41","volume":"6","author":"ME Platek","year":"2011","unstructured":"Platek ME, Merzianu M, Mashtare TL, et al. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol. 2011;6:41.","journal-title":"Radiat Oncol"},{"issue":"3","key":"887_CR26","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L","volume":"37","author":"S Kadish","year":"1976","unstructured":"Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer. 1976;37(3):1571\u20136.","journal-title":"Cancer"},{"issue":"5","key":"887_CR27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1227\/00006123-199305000-00002","volume":"32","author":"A Morita","year":"1993","unstructured":"Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993;32(5):706\u201314 (discussion 714\u2013705).","journal-title":"Neurosurgery"},{"issue":"8","key":"887_CR28","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1288\/00005537-199208000-00001","volume":"102","author":"P Dulguerov","year":"1992","unstructured":"Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970\u20131990. Laryngoscope. 1992;102(8):843\u20139.","journal-title":"Laryngoscope"},{"issue":"2","key":"887_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"key":"887_CR30","first-page":"24","volume-title":"Special tumors of the head and neck","author":"VJ Hyams","year":"1982","unstructured":"Hyams VJ. Olfactory neuroblastoma (case 6). In: Batsakis JG, Hyams VJ, Morales AR, editors. Special tumors of the head and neck. Chicago: ASCP Press; 1982. pp.\u00a024\u20139."},{"issue":"1","key":"887_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11912-014-0423-z","volume":"17","author":"RE Saade","year":"2015","unstructured":"Saade RE, Hanna EY, Bell D. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep. 2015;17(1):423.","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"887_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jocn.2012.05.029","volume":"20","author":"G Kaur","year":"2013","unstructured":"Kaur G, Kane AJ, Sughrue ME, et al. The prognostic implications of Hyam\u2019s subtype for patients with Kadish stage C esthesioneuroblastoma. J Clin Neurosci. 2013;20(2):281\u20136.","journal-title":"J Clin Neurosci"},{"issue":"6","key":"887_CR33","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.ejca.2012.12.008","volume":"49","author":"GG Malouf","year":"2013","unstructured":"Malouf GG, Casiraghi O, Deutsch E, Guigay J, Temam S, Bourhis J. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome. Eur J Cancer. 2013;49(6):1324\u201334.","journal-title":"Eur J Cancer"},{"issue":"5","key":"887_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/s-0032-1321512","volume":"73","author":"JJ Gompel Van","year":"2012","unstructured":"Van Gompel JJ, Giannini C, Olsen KD, et al. Long-term outcome of esthesioneuroblastoma: Hyams grade predicts patient survival. J Neurol Surg Part B. 2012;73(5):331\u20136.","journal-title":"J Neurol Surg Part B"},{"issue":"2","key":"887_CR35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12105-016-0743-4","volume":"11","author":"M Mandarano","year":"2017","unstructured":"Mandarano M, Colella R, Giansanti M, Sidoni A. Aberrant pattern of cytokeratin expression in olfactory neuroblastoma: a potential diagnostic pitfall. Head Neck Pathol. 2017;11(2):262\u20133.","journal-title":"Head Neck Pathol"},{"issue":"6","key":"887_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.anndiagpath.2015.06.008","volume":"19","author":"L Singh","year":"2015","unstructured":"Singh L, Ranjan R, Madan R, Arava SK, Deepak RK, Singh MK. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role? Ann Diagn Pathol. 2015;19(6):391\u20136.","journal-title":"Ann Diagn Pathol"},{"key":"887_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.oraloncology.2017.09.010","volume":"74","author":"M Turri-Zanoni","year":"2017","unstructured":"Turri-Zanoni M, Maragliano R, Battaglia P, et al. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: refinements in diagnostic criteria and impact of multimodal treatments on survival. Oral Oncol. 2017;74:21\u20139.","journal-title":"Oral Oncol"},{"issue":"1","key":"887_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12105-012-0336-9","volume":"6","author":"LD Thompson","year":"2012","unstructured":"Thompson LD, Seethala RR, Muller S. Ectopic sphenoid sinus pituitary adenoma (ESSPA) with normal anterior pituitary gland: a clinicopathologic and immunophenotypic study of 32 cases with a comprehensive review of the english literature. Head Neck Pathol. 2012;6(1):75\u2013100.","journal-title":"Head Neck Pathol"},{"issue":"2","key":"887_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cancergencyto.2006.09.024","volume":"173","author":"H Holland","year":"2007","unstructured":"Holland H, Koschny R, Krupp W, et al. Comprehensive cytogenetic characterization of an esthesioneuroblastoma. Cancer Genet Cytogenet. 2007;173(2):89\u201396.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"887_CR40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1750-3639.2004.tb00048.x","volume":"14","author":"U Bockmuhl","year":"2004","unstructured":"Bockmuhl U, You X, Pacyna-Gengelbach M, Arps H, Draf W, Petersen I. CGH pattern of esthesioneuroblastoma and their metastases. Brain Pathol. 2004;14(2):158\u201363.","journal-title":"Brain Pathol"},{"issue":"1","key":"887_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0165-4608(01)00659-8","volume":"136","author":"SH Riazimand","year":"2002","unstructured":"Riazimand SH, Brieger J, Jacob R, Welkoborsky HJ, Mann WJ. Analysis of cytogenetic aberrations in esthesioneuroblastomas by comparative genomic hybridization. Cancer Genet Cytogenet. 2002;136(1):53\u20137.","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"887_CR42","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/modpathol.2008.57","volume":"21","author":"M Guled","year":"2008","unstructured":"Guled M, Myllykangas S, Frierson HF Jr, Mills SE, Knuutila S, Stelow EB. Array comparative genomic hybridization analysis of olfactory neuroblastoma. Mod Pathol. 2008;21(6):770\u20138.","journal-title":"Mod Pathol"},{"issue":"12","key":"887_CR43","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/gcc.22288","volume":"54","author":"R Valli","year":"2015","unstructured":"Valli R, De Bernardi F, Frattini A, et al. Comparative genomic hybridization on microarray (a-CGH) in olfactory neuroblastoma: analysis of ten cases and review of the literature. Genes Chromosom Cancer. 2015;54(12):771\u20135.","journal-title":"Genes Chromosom Cancer"},{"issue":"3\u20134","key":"887_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000236047","volume":"77","author":"L Mao","year":"2009","unstructured":"Mao L, Xia YP, Zhou YN, et al. Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma. Oncology. 2009;77(3\u20134):231\u201343.","journal-title":"Oncology"},{"issue":"3","key":"887_CR45","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.4238\/2013.September.10.4","volume":"12","author":"DC Gonzalez-Kristeller","year":"2013","unstructured":"Gonzalez-Kristeller DC, Gutiyama LM, Campos AH, Soares FA, Brentani H, Malnic B. Odorant receptor genes are expressed in olfactory neuroblastoma. Genet Mol Res. 2013;12(3):3479\u201387.","journal-title":"Genet Mol Res"},{"issue":"12","key":"887_CR46","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1073\/pnas.90.12.5648","volume":"90","author":"DW Ball","year":"1993","unstructured":"Ball DW, Azzoli CG, Baylin SB, et al. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci USA. 1993;90(12):5648\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"41","key":"887_CR47","doi-asserted-by":"publisher","first-page":"14788","DOI":"10.1073\/pnas.1410419111","volume":"111","author":"A Augustyn","year":"2014","unstructured":"Augustyn A, Borromeo M, Wang T, et al. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Proc Natl Acad Sci USA. 2014;111(41):14788\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"887_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/bbrc.2000.3090","volume":"274","author":"P Persson","year":"2000","unstructured":"Persson P, Jogi A, Grynfeld A, Pahlman S, Axelson H. HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a functional complex. Biochem Biophys Res Commun. 2000;274(1):22\u201331.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"887_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1309\/QD0K9Q1JBH6B5GQQ","volume":"122","author":"P Mhawech","year":"2004","unstructured":"Mhawech P, Berczy M, Assaly M, et al. Human achaete-scute homologue (hASH1) mRNA level as a diagnostic marker to distinguish esthesioneuroblastoma from poorly differentiated tumors arising in the sinonasal tract. Am J Clin Pathol. 2004;122(1):100\u20135.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"887_CR50","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.humpath.2008.07.019","volume":"40","author":"B Cordes","year":"2009","unstructured":"Cordes B, Williams MD, Tirado Y, et al. Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification. Hum Pathol. 2009;40(3):283\u201392.","journal-title":"Hum Pathol"},{"issue":"3","key":"887_CR51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.anndiagpath.2015.03.009","volume":"19","author":"MW Taggart","year":"2015","unstructured":"Taggart MW, Hanna EY, Gidley P, Weber RS, Bell D. Achaete-scute homolog 1 expression closely correlates with endocrine phenotype and degree of differentiation in sinonasal neuroendocrine tumors. Ann Diagn Pathol. 2015;19(3):154\u20136.","journal-title":"Ann Diagn Pathol"},{"issue":"7","key":"887_CR52","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1634\/theoncologist.2016-0287","volume":"22","author":"LM Gay","year":"2017","unstructured":"Gay LM, Kim S, Fedorchak K, et al. Comprehensive genomic profiling of esthesioneuroblastoma reveals additional treatment options. Oncologist. 2017;22(7):834\u201342.","journal-title":"Oncologist"},{"issue":"32","key":"887_CR53","doi-asserted-by":"publisher","first-page":"52584","DOI":"10.18632\/oncotarget.9683","volume":"7","author":"P Czapiewski","year":"2016","unstructured":"Czapiewski P, Kunc M, Haybaeck J. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment. Oncotarget. 2016;7(32):52584\u201396.","journal-title":"Oncotarget"},{"issue":"11","key":"887_CR54","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1158\/1541-7786.MCR-17-0135","volume":"15","author":"L LazoVega de la","year":"2017","unstructured":"Lazo de la Vega L, McHugh JB, Cani AK, et al. Comprehensive molecular profiling of olfactory neuroblastoma identifies potentially targetable FGFR3 amplifications. Mol Cancer Res. 2017;15(11):1551\u20137.","journal-title":"Mol Cancer Res"},{"issue":"4","key":"887_CR55","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/hed.23327","volume":"36","author":"TJ Ow","year":"2014","unstructured":"Ow TJ, Hanna EY, Roberts DB, et al. Optimization of long-term outcomes for patients with esthesioneuroblastoma. Head Neck. 2014;36(4):524\u201330.","journal-title":"Head Neck"},{"issue":"3","key":"887_CR56","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/pbc.25817","volume":"63","author":"R Venkatramani","year":"2016","unstructured":"Venkatramani R, Pan H, Furman WL, et al. Multimodality treatment of pediatric esthesioneuroblastoma. Pediatr Blood Cancer. 2016;63(3):465\u201370.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"887_CR57","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/hed.24822","volume":"39","author":"SY Su","year":"2017","unstructured":"Su SY, Bell D, Ferrarotto R, et al. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck. 2017;39(8):1671\u20139.","journal-title":"Head Neck"},{"issue":"1","key":"887_CR58","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12105-013-0513-5","volume":"9","author":"A Franchi","year":"2015","unstructured":"Franchi A, Rocchetta D, Palomba A, Degli Innocenti DR, Castiglione F, Spinelli G. Primary combined neuroendocrine and squamous cell carcinoma of the maxillary sinus: report of a case with immunohistochemical and molecular characterization. Head Neck Pathol. 2015;9(1):107\u201313.","journal-title":"Head Neck Pathol"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12105-018-0887-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-018-0887-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-018-0887-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T21:32:19Z","timestamp":1549661539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12105-018-0887-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,9]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1007\/s12105-018-0887-5","relation":{},"ISSN":["1936-055X","1936-0568"],"issn-type":[{"value":"1936-055X","type":"print"},{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,9]]},"assertion":[{"value":"9 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares that she has no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}